Literature DB >> 17211618

Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia.

Ju Mizuno1, Ikuto Yoshiya, Takeshi Yokoyama, Yoshitsugu Yamada, Hideko Arita, Kazuo Hanaoka.   

Abstract

OBJECTIVE: Landiolol hydrochloride is a new ultra-short-acting beta(1)-adrenergic receptor blocking agent that is used for patients with tachycardia during general anesthesia. The hemodynamic response to a beta-adrenergic receptor blocking agent is generally dependent on the subject. In the present investigation we investigated the effects of age and sex on the hemodynamic response to different doses of landiolol.
METHODS: Following a persistence of tachycardia for more than 1 min, landiolol was infused at 0.03125, 0.0625 and 0.125 mg kg(-1) min(-1) for 1 min followed by 0.01, 0.02 and 0.04 mg kg(-1)min(-1) for 10 min in groups L, M and H, respectively. Heart rate (HR), systolic (sBP) and diastolic blood pressure (dBP) were recorded each minute during the procedure. The respective changes were evaluated using logistic analysis with the equation Y(t) = p + (q - p)/[1 + exp {4m/(q - p))(k - t)}], where p, q, m and k indicate the upper asymptote, lower asymptote, maximum slope and time at the maximum slope.
RESULTS: Parameters q and k for HR in group H were smaller than those in group L, whereas the parameters for sBP and dBP were unchanged among the three groups. Parameter q for HR in group H decreased with age of the patient. There was no significant difference in the landiolol-induced change in HR between males and females.
CONCLUSION: The hemodynamic response to landiolol is reliably modeled by the logistic function, especially in terms of HR. Landiolol causes a rapid and dose-dependent decrease in HR, whereas landiolol-induced changes in sBP and dBP are independent of dose. The landiolol-induced decrease in HR becomes larger with aging, but shows no sex difference. The logistic model may be useful for studying hemodynamic responses to landiolol based on age and sex differences, and may allow development of an improved monitoring system. IMPLICATION STATEMENT: The logistic function reliably represents the hemodynamic responses to landiolol. Landiolol reduces HR rapidly and in a dose-dependent manner whereas landiolol-induced changes in sBP and dBP are independent of dose. A larger decrease in HR is caused by landiolol in elderly patients, but there is no sex difference in the landiolol-induced change in HR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211618     DOI: 10.1007/s00228-006-0249-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  44 in total

1.  On the reliable assessment of cardiovascular recovery: an application of curve-fitting techniques.

Authors:  N Christenfeld; L M Glynn; W Gerin
Journal:  Psychophysiology       Date:  2000-07       Impact factor: 4.016

2.  Managing a tachyarrhythmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting beta-adrenergic blocker.

Authors:  Junichi Ogata; Toru Yokoyama; Takashi Okamoto; Kouichiro Minami
Journal:  Anesth Analg       Date:  2003-07       Impact factor: 5.108

3.  Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.

Authors:  S Iguchi; H Iwamura; M Nishizaki; A Hayashi; K Senokuchi; K Kobayashi; K Sakaki; K Hachiya; Y Ichioka; M Kawamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-06       Impact factor: 1.645

4.  The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.

Authors:  Yutaka Oda; Kiyonobu Nishikawa; Ichiro Hase; Akira Asada
Journal:  Anesth Analg       Date:  2005-03       Impact factor: 5.108

5.  Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.

Authors:  A B Luzier; A Killian; J H Wilton; M F Wilson; A Forrest; D J Kazierad
Journal:  Clin Pharmacol Ther       Date:  1999-12       Impact factor: 6.875

6.  Changes in stroke volume with beta-blockade before and after 10 days of exercise training in men and women.

Authors:  C M Mier; M A Domenick; J H Wilmore
Journal:  J Appl Physiol (1985)       Date:  1997-11

7.  Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.

Authors:  A Sugiyama; A Takahara; K Hashimoto
Journal:  J Cardiovasc Pharmacol       Date:  1999-07       Impact factor: 3.105

8.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

Authors:  C F Minto; T W Schnider; T D Egan; E Youngs; H J Lemmens; P L Gambus; V Billard; J F Hoke; K H Moore; D J Hermann; K T Muir; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

Review 9.  Peri-operative beta-blockade and haemodynamic optimisation in patients with coronary artery disease and decreasing exercise capacity presenting for major noncardiac surgery.

Authors:  B M Biccard
Journal:  Anaesthesia       Date:  2004-01       Impact factor: 6.955

10.  Does perioperative myocardial ischemia lead to postoperative myocardial infarction?

Authors:  S Slogoff; A S Keats
Journal:  Anesthesiology       Date:  1985-02       Impact factor: 7.892

View more
  3 in total

1.  Anaphylactic shock in a patient with severe aortic stenosis treated with adrenaline and landiolol for circulatory management: A case report.

Authors:  Akihiro Yokoyama; Motohiro Sekino; Taiga Ichinomiya; Hironori Ishizaki; Keiko Ogami-Takamura; Takashi Egashira; Rintaro Yano; Sojiro Matsumoto; Ushio Higashijima; Tetsuya Hara
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

Review 2.  Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

3.  Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography.

Authors:  Rie Koyoshi; Yuhei Shiga; Yoshiaki Idemoto; Yoko Ueda; Kohei Tashiro; Takashi Kuwano; Ken Kitajima; Kanta Fujimi; Akira Kawamura; Masahiro Ogawa; Shin-Ichiro Miura
Journal:  J Clin Med Res       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.